Profil
Stephanie Vigue worked as a Finance Director at Sesen Bio, Inc. She then worked as a Manager-Corporate Accounting at Spectrum Pharmaceuticals, Inc. from 2014 to 2017.
In 2020, she worked as a Manager-Corporate Accounting & Controller at The Fi Co. Ms. Vigue received an undergraduate degree from Husson University.
Anciens postes connus de Stephanie Vigue
| Sociétés | Poste | Fin |
|---|---|---|
| The Fi Co. | Comptroller/Controller/Auditor | 01/09/2021 |
| SPECTRUM PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | 01/09/2017 |
| CARISMA THERAPEUTICS, INC. | Director of Finance/CFO | - |
Formation de Stephanie Vigue
| Husson University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| SPECTRUM PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Sesen Bio, Inc.
 Sesen Bio, Inc. Pharmaceuticals: MajorHealth Technology Sesen Bio, Inc. is a late-stage clinical company, which engages in the development of targeted fusion protein therapeutics. It offers Vicineum and Proxinium, which target tumor cell surface antigens that allow for rapid internalization into the targeted cancer cell and also have limited expression on normal cells. The company was founded by Reza Dana, K. Christopher Garcia, Gregory L. Verdine, Casey T. Weaver, and K. Dane Wittrup on February 25, 2008 and is headquartered in Cambridge, MA. | Health Technology |
| The Fi Co. |
